LU78690A1 - - Google Patents

Info

Publication number
LU78690A1
LU78690A1 LU7778690A LU78690A LU78690A1 LU 78690 A1 LU78690 A1 LU 78690A1 LU 7778690 A LU7778690 A LU 7778690A LU 78690 A LU78690 A LU 78690A LU 78690 A1 LU78690 A1 LU 78690A1
Authority
LU
Luxembourg
Application number
LU7778690A
Inventor
D Viza
D Adamopoulos
J Phillips
Original Assignee
Int Inst Of Differentiation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Inst Of Differentiation filed Critical Int Inst Of Differentiation
Publication of LU78690A1 publication Critical patent/LU78690A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU7778690A 1976-12-16 1977-12-14 LU78690A1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB52674/76A GB1594097A (en) 1976-12-16 1976-12-16 Production of specific immune nucleic acids cell dialysates and antibodies

Publications (1)

Publication Number Publication Date
LU78690A1 true LU78690A1 (da) 1979-02-02

Family

ID=10464835

Family Applications (1)

Application Number Title Priority Date Filing Date
LU7778690A LU78690A1 (da) 1976-12-16 1977-12-14

Country Status (14)

Country Link
US (1) US4224404A (da)
JP (1) JPS5375321A (da)
AU (1) AU3151977A (da)
BE (1) BE861857A (da)
CA (1) CA1110988A (da)
DK (1) DK557477A (da)
ES (1) ES465059A1 (da)
FI (1) FI773784A (da)
FR (1) FR2374330A1 (da)
GB (1) GB1594097A (da)
IE (1) IE46215B1 (da)
LU (1) LU78690A1 (da)
NL (1) NL7713832A (da)
NO (1) NO774311L (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091760B1 (en) * 1982-04-09 1986-07-02 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Anti immune complex antibody and preparation thereof
DE3245665A1 (de) * 1982-05-04 1983-11-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4851510A (en) * 1984-11-30 1989-07-25 Wadley Technologies, Inc. Monoclonal antibodies to novel melanoma-associated antigens
US5004681B1 (en) * 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US6214804B1 (en) 1989-03-21 2001-04-10 Vical Incorporated Induction of a protective immune response in a mammal by injecting a DNA sequence
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
DK0465529T3 (da) * 1989-03-21 1998-10-05 Vical Inc Ekspression af exogene polynukleotidsekvenser i et hvirveldyr
US5693622A (en) * 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6867195B1 (en) 1989-03-21 2005-03-15 Vical Incorporated Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
DE69031951T2 (de) * 1989-11-16 1998-08-13 Du Pont Transformation von tierischen Hautzellen mit hilfe von Partikeln
US6706694B1 (en) 1990-03-21 2004-03-16 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate
US20030186913A1 (en) * 1990-03-21 2003-10-02 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate
US6228844B1 (en) 1991-11-12 2001-05-08 Vical Incorporated Stimulating vascular growth by administration of DNA sequences encoding VEGF
ATE302854T1 (de) * 1993-01-26 2005-09-15 Univ Pennsylvania Zusammensetzungen und verfahren zur verabreichung von genetischem material
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5981505A (en) * 1993-01-26 1999-11-09 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
US20040087521A1 (en) * 1993-03-18 2004-05-06 Merck & Co., Inc. Nucleic acid pharmaceuticals-influenza matrix
EP0702516A4 (en) * 1993-06-01 1998-04-22 Life Technologies Inc GENETIC IMMUNIZATION WITH CATIONIC LIPIDS
US6348449B1 (en) 1993-09-21 2002-02-19 The Trustees Of The University Of Pennsylvania Methods of inducing mucosal immunity
IL112820A0 (en) * 1994-03-07 1995-05-26 Merck & Co Inc Coordinate in vivo gene expression
US6995008B1 (en) 1994-03-07 2006-02-07 Merck & Co., Inc. Coordinate in vivo gene expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617545C2 (de) 1967-06-19 1983-11-03 Diether Prof. Dr. Bern Jachertz Verwendung von informatorischer Ribonucleinsäure als Vaccine
GB1443948A (en) 1972-10-20 1976-07-28 Piktor Ltd Production of immunological material

Also Published As

Publication number Publication date
GB1594097A (en) 1981-07-30
NL7713832A (nl) 1978-06-20
ES465059A1 (es) 1978-09-01
IE46215B1 (en) 1983-04-06
BE861857A (fr) 1978-06-14
FR2374330B3 (da) 1981-02-06
DK557477A (da) 1978-06-17
FI773784A (fi) 1978-06-17
AU3151977A (en) 1979-06-21
US4224404A (en) 1980-09-23
IE46215L (en) 1978-06-16
CA1110988A (en) 1981-10-20
FR2374330A1 (fr) 1978-07-13
JPS5375321A (en) 1978-07-04
NO774311L (no) 1978-06-19

Similar Documents

Publication Publication Date Title
FR2372953B1 (da)
JPS5539222B2 (da)
JPS557598Y2 (da)
JPS569478B2 (da)
JPS52132388U (da)
JPS5347018U (da)
JPS5425392Y2 (da)
JPS5552480Y2 (da)
JPS5645722Y2 (da)
JPS5551360B2 (da)
JPS5614424B2 (da)
JPS5637601B2 (da)
JPS52135190U (da)
JPS52155621U (da)
DK529676A (da)
JPS52130801U (da)
JPS52153387U (da)
JPS5327430U (da)
JPS533709U (da)
JPS5349378U (da)
JPS5377995U (da)
CH603374A5 (da)
CH590040A5 (da)
CH595975A5 (da)
CH603150A5 (da)